Product
64Cu-SARTATE
Aliases
64Cu-MeCOSar-Octreotate, Cu-64 SARTATE, copper 64 SARTATE
2 clinical trials
2 indications
Indication
Neuroendocrine TumorsIndication
NeuroblastomaClinical trial
Positron Emission Tomography Imaging of Participants With Known or Suspected Neuroendocrine Tumours Using 64Cu SARTATE: A Multi-Centre, Single Arm, Non-Randomised, Blinded-Review, Phase II StudyStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical TrialStatus: Recruiting, Estimated PCD: 2028-12-01